ZYMAR® (gatifloxacin ophthalmic solution) solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria:

Cornyebacterium propinquum*
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus mitis*
Streptococcus pneumoniae

Aerobic Gram-Negative Bacteria:

Haemophilus influenzae

* Efficacy for this organism was studied in fewer than 10 infections

The recommended dosage regimen for the treatment of bacterial conjunctivitis is:

Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.

Days 3 through 7: Instill one drop up to four times daily while awake.

ZYMAR® (gatifloxacin ophthalmic solution) (gatifloxacin ophthalmic solution) 0.3% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip and a tan, high impact polystyrene (HIPS) cap in the following sizes:

2.5 mL in a 6 mL bottle- NDC 0023-9218-03

5 mL in an 10 mL bottle- NDC 0023-9218-05

Note: Store at 15°-25°C (59°-77°F). Protect from freezing.

Revised August 2004 ©2004 Allergan, Inc. Irvine, CA 92612, U.S.A. Licensed from: Kyorin Pharmaceuticals Co., Ltd. Marks owned by Allergan, Inc.
FDA Rev date: 6/20/2005

Last reviewed on RxList: 8/14/2007
This monograph has been modified to include the generic and brand name in many instances.